BNP Paribas Financial Markets’s vTv Therapeutics VTVT Stock Holding History

BNP Paribas Financial Markets’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.8K	Buy	1,802 +1,793	+19,922%	+$62.2K	﹤0.01%	4737
2026 Q1	$357	Hold	9	–	–	﹤0.01%	5572
2025 Q4	$360	Hold	9	–	–	﹤0.01%	5509
2025 Q3	$210	Hold	9	–	–	﹤0.01%	5390
2025 Q2	$135	Hold	9	–	–	﹤0.01%	5310
2025 Q1	$156	Hold	9	–	–	﹤0.01%	5230
2024 Q4	$124	Hold	9	–	–	﹤0.01%	5265
2024 Q3	$121	Hold	9	–	–	﹤0.01%	4058
2024 Q2	$159	Hold	9	–	–	﹤0.01%	3949
2024 Q1	$212	Buy	+9	New	+$114	﹤0.01%	3944
2023 Q4	–	Sell	-8	Closed	-$157	–	4109
2023 Q3	$157	Hold	8	–	–	﹤0.01%	3835
2023 Q2	$243	Hold	8	–	–	﹤0.01%	3822
2023 Q1	$266	Hold	8	–	–	﹤0.01%	3752
2022 Q4	$219	Hold	8	–	–	﹤0.01%	3920
2022 Q3	$320	Hold	8	–	–	﹤0.01%	4565
2022 Q2	$248	Hold	8	–	–	﹤0.01%	3985
2022 Q1	$238	Sell	8 -12	-60%	-$359	﹤0.01%	4077
2021 Q4	$793	Sell	20 -3	-13%	-$161	﹤0.01%	4072
2021 Q3	$1.39K	Sell	23 -2	-8%	-$151	﹤0.01%	3840
2021 Q2	$2.24K	Sell	25 -5	-17%	-$507	﹤0.01%	3872
2021 Q1	$3.38K	Sell	30 -3	-9%	-$295	﹤0.01%	3882
2020 Q4	$2.47K	Sell	33 -24	-42%	-$1.84K	﹤0.01%	3990
2020 Q3	$4.03K	Buy	57 +48	+533%	+$4.22K	﹤0.01%	4026
2020 Q2	$826	Buy	+9	New	+$889	﹤0.01%	4195
2020 Q1	–	Hold	0	–	–	–	4293
2019 Q4	–	Hold	0	–	–	–	4403
2019 Q3	–	Hold	0	–	–	–	4476
2019 Q2	–	Hold	0	–	–	–	4505
2019 Q1	–	Hold	0	–	–	–	4246
2018 Q4	–	Hold	0	–	–	–	4274
2018 Q3	–	Hold	0	–	–	–	4420
2018 Q2	–	Sell	-38	Closed	-$2.81K	–	4383
2018 Q1	$6.22K	Sell	38 -5	-12%	-$1.22K	﹤0.01%	4043
2017 Q4	$10.4K	Buy	43 +21	+95%	+$4.71K	﹤0.01%	4027
2017 Q3	$5.33K	Sell	22 -2	-8%	-$399	﹤0.01%	3968
2017 Q2	$4.69K	Buy	24 +20	+500%	+$4.17K	﹤0.01%	4033
2017 Q1	$1.03K	Sell	4 -9	-69%	-$2.05K	﹤0.01%	3692
2016 Q4	$2.53K	Sell	13 -2	-13%	-$460	﹤0.01%	3879
2016 Q3	$4.34K	Buy	15 +5	+50%	+$1.2K	﹤0.01%	3409
2016 Q2	$2.25K	Buy	+10	New	+$2.3K	﹤0.01%	3440
2016 Q1	–	Sell	-27	Closed	-$7.37K	–	3088
2015 Q4	$7.37K	Sell	27 -2	-7%	-$561	﹤0.01%	3427
2015 Q3	$7.43K	Buy	+29	New	+$10.1K	﹤0.01%	3453

Other funds holding VTVT

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

BNP Paribas Financial Markets's VTVT Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its vTv Therapeutics (VTVT) stake by 19,922% in Q2 2026, buying an estimated $62.2K and bringing the position to 1,802 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4737.

BNP Paribas Financial Markets first reported a position in VTVT in Q3 2015 and has held it in 34 quarters since. 29 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

BNP Paribas Financial Markets held 1,802 shares of vTv Therapeutics worth $67.8K as of Q2 2026.
BNP Paribas Financial Markets bought 1,793 vTv Therapeutics shares in Q2 2026, an estimated $62.2K.
vTv Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4737 holding.
BNP Paribas Financial Markets first reported a position in vTv Therapeutics in Q3 2015 and has held it in 34 quarters since.
29 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.